Back to search
FDAFDA · Food and drugs·Recall number D-807-2013

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Published July 24, 2013 · Recall initiated: June 13, 2013

Summary

FDA records drug Class III recall D-807-2013, published July 24, 2013 and initiated June 13, 2013. Recalling firm: Bayer HealthCare Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 194.62 kg; Lot: Lot 87100040. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bayer HealthCare Pharmaceuticals Inc.
Distributor
NY, CA
Lot
Lot 87100040
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin recalled?

Yes. FDA published recall D-807-2013 on July 24, 2013. Reported hazard: Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter